دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
Creeping fat in Crohn’s disease: an immunometabolic imbalance worth targeting?
doi : 10.1093/ecco-jcc/jjaf109
Volume 19, Issue 7, July 2025
Ultrasound-guided strategies in ulcerative colitis: early prediction and targeting
doi : 10.1093/ecco-jcc/jjaf113
Long-term efficacy of JAK inhibitors in ulcerative colitis: tipping toward safe success
doi : 10.1093/ecco-jcc/jjaf114
Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review
doi : 10.1093/ecco-jcc/jjaf111
Lysophosphatidylcholine-induced aberrant adipogenesis in mesenchymal stem cells and impaired antibacterial function in adipocytes of creeping fat
doi : 10.1093/ecco-jcc/jjaf019
Gaps between European Crohn’s Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY survey
doi : 10.1093/ecco-jcc/jjaf094
ST6GAL1 promotes IBD B cell recruitment to the inflamed colon in a CD22-dependent mechanism
doi : 10.1093/ecco-jcc/jjaf097
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn’s disease: results from the phase 3 VIVID-1 study
doi : 10.1093/ecco-jcc/jjaf100
Association between food diversity in the infant period and the risk of inflammatory bowel disease: a nationwide cohort study in South Korea
doi : 10.1093/ecco-jcc/jjaf101
A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn’s disease: the TEOREM trial
doi : 10.1093/ecco-jcc/jjaf093
Gaps between European Crohn’s and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey
doi : 10.1093/ecco-jcc/jjaf105
Endo-Histo foundational fusion model: a novel artificial intelligence for assessing histologic remission and response to therapy in ulcerative colitis clinical trial
doi : 10.1093/ecco-jcc/jjaf108
Pharmacological inhibitors of the gamma-secretase enzyme complex disrupt epithelial cell function triggering colitis in mice
doi : 10.1093/ecco-jcc/jjaf096
Impact of complete vs partial endoscopic healing on long-term outcomes in Crohn’s disease: a prospective multicenter study
doi : 10.1093/ecco-jcc/jjaf104
Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison
doi : 10.1093/ecco-jcc/jjae188
Achievement of long-term treatment goals in upadacitinib-treated patients with moderately to severely active ulcerative colitis: a post hoc analysis of phase 3 trial data
doi : 10.1093/ecco-jcc/jjaf095
Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer
doi : 10.1093/ecco-jcc/jjaf102
The long-term disease course of microscopic colitis: a European prospective incident cohort study
doi : 10.1093/ecco-jcc/jjaf110
Antigen-driven expansion of public clonal T-cell populations in inflammatory bowel diseases
doi : 10.1093/ecco-jcc/jjaf048
Phenome-wide association study of monogenic inflammatory bowel disease genes in diverse biobanks identifies population-specific and shared Goldilocks alleles: implications for Precision Medicine
doi : 10.1093/ecco-jcc/jjaf098
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study
doi : 10.1093/ecco-jcc/jjaf115
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications
doi : 10.1093/ecco-jcc/jjaf106
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2: IBD scores and general principles and technical aspects
doi : 10.1093/ecco-jcc/jjaf107
